Atlas FDA

Predicate Research Report · generated 2026-08-23 · Print / save as PDF · Save to account

Onset Medical Corporation · Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

126 daysmedian FDA review time
358 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K152498SoloPath Re-Collapsible Access SystemOnset Medical Corporation2016-01-051262
K121404SOLOPATH RE-COLLAPSIBLE ACCESS SYSTEMOnset Medical Corporation2013-05-033580
K112629ONSET ACCESS CATHETER SYSTEMOnset Medical Corporation2011-10-11320
K100819THE SOLOPATH BALLOON EXPANDABLE TRANSFEMORAL INTRODUCEROnset Medical Corporation2010-08-021321
K092014SOLOPATH BALLOON EXPANDABLE TRANSFEMORAL INTRODUCEROnset Medical Corporation2009-10-08940
K062852BALLOON EXPANDABLE TRANSSEPTAL INDRODUCER, MODELS BETI-1840 Onset Medical Corporation2007-02-231510
K061009PATHWAY BALLOON EXPANDABLE URETERAL ACCESS SHEATH, MODEL BEUOnset Medical Corporation2006-05-02209
K043254PATHWAY URETERAL ACCESS SHEATH, PATHWAY EXPANDABLE URETERAL Onset Medical Corporation2005-02-10780

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda